EHHADH expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.651200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.830200E-02
Normal-vs-Stage2
2.748000E-01
Normal-vs-Stage3
8.135400E-01
Normal-vs-Stage4
1.667970E-01
Stage1-vs-Stage2
8.895600E-02
Stage1-vs-Stage3
1.818010E-02
Stage1-vs-Stage4
9.665000E-01
Stage2-vs-Stage3
3.161400E-04
Stage2-vs-Stage4
1.836150E-01
Stage3-vs-Stage4
1.231790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.826000E-01
Normal-vs-AfricanAmerican
3.117000E-01
Normal-vs-Asian
3.435600E-01
Caucasian-vs-AfricanAmerican
9.452600E-01
Caucasian-vs-Asian
7.029400E-01
AfricanAmerican-vs-Asian
8.350800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.663000E-01
Normal-vs-Female
2.793200E-01
Male-vs-Female
6.682400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.432000E-02
Normal-vs-Age(41-60Yrs)
2.078800E-01
Normal-vs-Age(61-80Yrs)
3.384000E-01
Normal-vs-Age(81-100Yrs)
2.463600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.860600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.281600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.213800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.998440E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.712000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.940200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.080400E-01
Normal-vs-Daily Drinker
6.416000E-01
Normal-vs-Weekly Drinker
5.119200E-01
Normal-vs-Occasional Drinker
9.758000E-02
Normal-vs-Social Drinker
2.058400E-01
Non Drinker-vs-Daily Drinker
1.797790E-01
Non Drinker-vs-Weekly Drinker
7.465000E-01
Non Drinker-vs-Occasional Drinker
1.032370E-01
Non Drinker-vs-Social Drinker
3.367600E-01
Daily Drinker-vs-Weekly Drinker
4.808400E-01
Daily Drinker-vs-Occasional Drinker
7.179300E-03
Daily Drinker-vs-Social Drinker
4.840400E-02
Weekly Drinker-vs-Occasional Drinker
1.354430E-01
Weekly Drinker-vs-Social Drinker
3.329800E-01
Occasional Drinker-vs-Social Drinker
6.437000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.318400E-02
Normal-vs-Grade 2
1.897910E-02
Normal-vs-Grade 3
7.400300E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.874600E-01
Grade 1-vs-Grade 3
3.276100E-02
Grade 1-vs-Grade 4
3.318400E-02
Grade 2-vs-Grade 3
4.511700E-02
Grade 2-vs-Grade 4
1.897910E-02
Grade 3-vs-Grade 4
7.400300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.703000E-01
Normal-vs-NonDiabetic
2.247200E-01
Diabetic-vs-NonDiabetic
2.868000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.200200E-01
Normal-vs-NoPancreatitis
2.595800E-01
Pancreatitis-vs-NoPancreatitis
7.464400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.877400E-01
Normal-vs-N1
2.261000E-01
N0-vs-N1
5.041000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.042170E-01
Normal-vs-TP53-NonMutant
2.563800E-01
TP53-Mutant-vs-TP53-NonMutant
3.954800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
